Actome focuses on developing emulsion coupling technology for life science research and personalized medicine.
Actome's investors include European Innovation Council, Qiagen, b.value AG.
Actome is headquartered in Freiburg Im Breisgau, Germany.
Actome focuses on developing emulsion coupling technology for life science research and personalized medicine.
Actome is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Actome — Funding & Investors." VCBacked, December 19, 2022, https://www.vcbacked.co/company/actome. Accessed July 19, 2026.
VCBacked. (2022). Actome — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/actome
{{cite web |title=Actome — Funding & Investors |url=https://www.vcbacked.co/company/actome |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated